Portable X-rays for TB
(SPOT-TB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
SPOT-TB (Screening with Portable X-rays for rapid recOgniTion of TB) is a prospective study evaluating a community-based tuberculosis (TB) screening strategy for migrant populations in New York City. The screening intervention integrates mobile ultra-portable digital chest radiography with artificial intelligence-assisted image interpretation, tuberculosis symptom assessment, latent tuberculosis infection testing, and HIV testing. Participants with concerning screening findings are referred for appropriate clinical evaluation. The study will evaluate the feasibility, acceptability, and effectiveness of this integrated screening strategy for improving early identification of active pulmonary tuberculosis and linkage to care in community settings.
Are You a Good Fit for This Trial?
This trial is for adults (18+) who have moved to the US within the past 2 years and identify as migrants. It focuses on people living in New York City.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
The study tests a mobile screening program using portable chest X-rays with AI analysis, symptom checks, TB infection testing, and HIV testing to find tuberculosis early among migrant communities.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants undergo the SPOT-TB screening strategy, which includes symptom screening, chest radiography interpreted using AI software, HIV testing, and collection of sputum for confirmatory microbiologic testing when indicated.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.